FBTCX: Fidelity Advisor® Biotechnology C

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

FBTCX Fidelity Advisor® Biotechnology C


Profile

FBTCX - Profile

Vitals

  • YTD Return 11.4%
  • 3 Yr Annualized Return 8.3%
  • 5 Yr Annualized Return -0.3%
  • Net Assets $2.41 B
  • Holdings in Top 10 59.0%

52 WEEK LOW AND HIGH

$26.03
$18.09
$28.13

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.78%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 62.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $0
  • IRA $500

Fund Classification


Distributions

  • YTD Total Return 11.4%
  • 3 Yr Annualized Total Return 8.3%
  • 5 Yr Annualized Total Return 0.8%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.61%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name
    Fidelity Advisor® Biotechnology Fund
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Dec 27, 2000
  • Shares Outstanding
    N/A
  • Share Class
    C
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Eirene Kontopoulos

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.


Categories

Fund Company Quick Screens

FBTCX - Fund Company Quick Screens


Performance

FBTCX - Performance

Return Ranking - Trailing

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.4% -3.8% 17.7% 24.81%
1 Yr 19.2% -0.9% 30.4% 34.13%
3 Yr 8.3%* -11.5% 22.1% 34.55%
5 Yr -0.3%* -11.6% 12.2% 45.63%
10 Yr 15.5%* -1.2% 17.1% 4.82%

* Annualized

Return Ranking - Calendar

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
2019 15.6% 5.7% 55.4% 74.14%
2018 -7.0% -25.3% 21.5% 45.45%
2017 24.8% -10.8% 43.9% 17.59%
2016 -24.1% -31.6% 6.9% 88.57%
2015 4.7% -20.4% 13.8% 14.00%

Total Return Ranking - Trailing

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.4% -3.8% 17.7% 24.81%
1 Yr 19.2% -0.9% 30.4% 34.13%
3 Yr 8.3%* -11.5% 25.2% 49.09%
5 Yr 0.8%* -11.6% 16.9% 58.25%
10 Yr 17.3%* -1.2% 19.4% 16.87%

* Annualized

Total Return Ranking - Calendar

Period FBTCX Return Category Return Low Category Return High Rank in Category (%)
2019 15.6% 5.7% 55.4% 74.14%
2018 -7.0% -25.3% 22.2% 53.64%
2017 24.8% -10.8% 45.8% 19.44%
2016 -24.1% -26.4% 8.7% 97.14%
2015 10.5% -16.6% 15.2% 24.00%

NAV & Total Return History


Holdings

FBTCX - Holdings

Concentration Analysis

FBTCX Category Low Category High FBTCX % Rank
Net Assets 2.41 B 2.28 M 49 B 20.90%
Number of Holdings 81 27 435 65.67%
Net Assets in Top 10 1.46 B 579 K 18.8 B 15.67%
Weighting of Top 10 58.96% 21.5% 76.0% 7.46%

Top 10 Holdings

  1. Regeneron Pharmaceuticals Inc 10.69%
  2. Amgen Inc 10.18%
  3. AbbVie Inc 9.96%
  4. Vertex Pharmaceuticals Inc 7.95%
  5. Alexion Pharmaceuticals Inc 5.37%
  6. argenx SE ADR 3.21%
  7. Biomarin Pharmaceutical Inc 3.17%
  8. Ascendis Pharma A/S ADR 2.91%
  9. Neurocrine Biosciences Inc 2.79%
  10. Alnylam Pharmaceuticals Inc 2.72%

Asset Allocation

Weighting Return Low Return High FBTCX % Rank
Stocks
98.43% 65.31% 100.23% 31.34%
Cash
0.81% -0.23% 34.69% 76.87%
Other
0.75% -1.66% 9.19% 25.37%
Preferred Stocks
0.00% 0.00% 4.57% 74.63%
Convertible Bonds
0.00% 0.00% 0.00% 67.91%
Bonds
0.00% 0.00% 16.54% 70.15%

Stock Sector Breakdown

Weighting Return Low Return High FBTCX % Rank
Healthcare
100.00% 60.00% 100.00% 29.85%
Utilities
0.00% 0.00% 0.00% 67.91%
Technology
0.00% 0.00% 20.28% 68.66%
Real Estate
0.00% 0.00% 5.63% 69.40%
Industrials
0.00% 0.00% 6.39% 69.40%
Financial Services
0.00% 0.00% 1.55% 75.37%
Energy
0.00% 0.00% 0.00% 67.91%
Communication Services
0.00% 0.00% 2.60% 67.91%
Consumer Defense
0.00% 0.00% 36.48% 70.15%
Consumer Cyclical
0.00% 0.00% 1.06% 67.91%
Basic Materials
0.00% 0.00% 2.52% 75.37%

Stock Geographic Breakdown

Weighting Return Low Return High FBTCX % Rank
US
87.85% 53.12% 99.43% 11.94%
Non US
10.58% 0.00% 45.40% 76.87%

Expenses

FBTCX - Expenses

Operational Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.78% 0.10% 25.14% 31.82%
Management Fee 0.54% 0.00% 1.25% 13.43%
12b-1 Fee 1.00% 0.00% 1.00% 91.67%
Administrative Fee N/A 0.03% 0.40% N/A

Sales Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load 1.00% 1.00% 5.00% 71.43%

Trading Fees

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 90.24%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 62.00% 0.70% 248.00% 76.92%

Distributions

FBTCX - Distributions

Dividend Yield Analysis

FBTCX Category Low Category High FBTCX % Rank
Dividend Yield 0.00% 0.00% 0.06% 67.91%

Dividend Distribution Analysis

FBTCX Category Low Category High Category Mod
Dividend Distribution Frequency None Annually Annually Annually

Net Income Ratio Analysis

FBTCX Category Low Category High FBTCX % Rank
Net Income Ratio -0.61% -2.53% 2.12% 80.45%

Capital Gain Distribution Analysis

FBTCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

FBTCX - Fund Manager Analysis

Managers

Eirene Kontopoulos


Start Date

Tenure

Tenure Rank

Jul 15, 2018

2.05

2.1%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.16 22.89 8.72 20.26